Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
bleomycin sulfate, Quantity: 30 IU
Hospira Australia Pty Ltd
Injection, powder for
Excipient Ingredients: sulfuric acid; sodium hydroxide
Intravenous, Subcutaneous, Intramuscular
1 x 30 IU vial
Medicine Listed (Export Only)
Not scheduled. Not considered by committee
Bleomycin injection should be considered a palliative treatment. It has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other chemotherapeutic agents. Squamous cell carcinoma, lymphomas and testicular carcinomas.
Visual Identification: A white to pale yellow powder or plug.; Container Type: Vial; Container Life Time: 2 Years
Licence status A
2001-10-10